Maximise the Impact of Precision Gene Editing to Drive Biomedical Applications & Future Breakthrough Therapies

With recent data questioning ‘precision’ editing, now is the time to ensure your CRISPR studies are fully optimised for greater specificity and efficiency with advanced verification protocols and off-target analysis. Discover how the best in the industry are developing innovative solutions to combat in vivo delivery challenges for biomedical research and therapeutic advancements to advance future breakthrough gene therapies.

With CRISPR officially cemented as THE editing tool transforming basic research and pharma R&D, the 3rd CRISPR Precision Genome Editing Europe 2018 is the meeting you cannot miss to keep up to date with vital developments in an industry that’s showing no signs of slowing down.